id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0121-0005,FDA,FDA-2002-E-0121,Letter from U.S. Patent and Trademark Office to Haugen Law Firm PLLP,Rule,Certificate Extending Patent Term,2006-09-15T04:00:00Z,2006,9,,,2025-10-08T17:00:29Z,,0,0,090000648049044a
FDA-2002-E-0121-0004,FDA,FDA-2002-E-0121,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-02-27T05:00:00Z,2006,2,,,2025-10-08T16:58:24Z,,0,0,0900006480490447
FDA-2002-E-0121-0003,FDA,FDA-2002-E-0121,Determination of Regulatory Review Period for Purposes of Patent Extension; ATS Open Pivot Bileaf Heart Valve,Notice,General Notice,2005-07-27T04:00:00Z,2005,7,2005-07-27T04:00:00Z,2006-01-24T04:59:59Z,2025-10-08T16:53:49Z,05-14748,0,0,0900006480490444
FDA-2002-E-0121-0002,FDA,FDA-2002-E-0121,Letter from FDA CDER to U.S. Trademark and Patent Office,Other,Letter(s),2005-07-18T04:00:00Z,2005,7,,,2025-10-08T16:50:12Z,,0,0,0900006480490442
FDA-2002-E-0121-0001,FDA,FDA-2002-E-0121,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2005-07-14T04:00:00Z,2005,7,,,2025-10-08T16:47:54Z,,0,0,09000064804903bd